ARTIVION, INC. (AORT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 363.42M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.07B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | $363.42M | (m) | (m) | $1.07B | (m) |
| 2026-03-31 | (m) | (m) | $0.00 | $215.35M | (m) | (m) | $883.16M | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $215.11M | (m) | (m) | $884.80M | (m) |
| 2025-09-30 | (m) | (m) | $0.00 | $214.87M | (m) | (m) | $857.66M | (m) |
| 2025-06-30 | (m) | (m) | $73.00K | $215.54M | (m) | (m) | $838.39M | (m) |
| 2025-03-31 | (m) | (m) | $135.00K | $314.61M | (m) | (m) | $791.16M | (m) |
| 2024-12-31 | (m) | (m) | $195.00K | $314.15M | (m) | (m) | $789.10M | (m) |
| 2024-09-30 | (m) | (m) | $99.70M | $214.27M | (m) | (m) | $803.14M | (m) |
| 2024-06-30 | (m) | (m) | $268.00K | $313.30M | (m) | (m) | $789.54M | (m) |
| 2024-03-31 | (m) | (m) | $270.00K | $313.00M | (m) | (m) | $784.01M | (m) |
| 2023-12-31 | (m) | (m) | $1.45M | $305.53M | (m) | (m) | $792.40M | (m) |
| 2023-09-30 | (m) | (m) | $1.55M | $305.88M | (m) | (m) | $774.79M | (m) |
| 2023-06-30 | (m) | (m) | $1.56M | $306.11M | (m) | (m) | $777.86M | (m) |
| 2023-03-31 | (m) | (m) | $1.62M | $306.28M | (m) | (m) | $757.07M | (m) |
| 2022-12-31 | (m) | (m) | $1.61M | $306.50M | (m) | (m) | $762.80M | (m) |
| 2022-09-30 | (m) | (m) | $1.56M | $306.67M | (m) | (m) | $742.73M | (m) |
| 2022-06-30 | (m) | (m) | $1.59M | $306.94M | (m) | (m) | $764.86M | (m) |
| 2022-03-31 | (m) | (m) | $1.62M | $307.23M | (m) | (m) | $781.86M | (m) |
| 2021-12-31 | (m) | (m) | $1.63M | $307.49M | (m) | (m) | $793.05M | (m) |
| 2021-09-30 | (m) | (m) | $1.64M | $307.76M | (m) | (m) | $818.65M | (m) |
| 2021-06-30 | (m) | (m) | $1.65M | $308.05M | (m) | (m) | $810.50M | (m) |
| 2021-03-31 | (m) | (m) | $1.17M | $310.06M | (m) | (m) | $794.83M | (m) |
| 2020-12-31 | (m) | (m) | $1.20M | $290.47M | (m) | (m) | $789.40M | (m) |
| 2020-09-30 | (m) | (m) | $1.17M | $289.70M | (m) | (m) | $782.20M | (m) |
| 2020-06-30 | (m) | (m) | $1.14M | $288.95M | (m) | (m) | $693.25M | (m) |
| 2020-03-31 | (m) | (m) | $1.16M | $244.23M | (m) | (m) | $621.03M | (m) |
| 2019-12-31 | (m) | (m) | $1.16M | $214.57M | (m) | (m) | $605.65M | (m) |
| 2019-09-30 | (m) | (m) | $1.14M | $214.79M | (m) | (m) | $592.60M | (m) |
| 2019-06-30 | (m) | (m) | $1.16M | $215.01M | (m) | (m) | $597.12M | (m) |
| 2019-03-31 | (m) | (m) | $1.15M | $215.26M | (m) | (m) | $586.93M | (m) |
| 2018-12-31 | (m) | (m) | $1.16M | $215.72M | (m) | (m) | $571.09M | (m) |
| 2018-09-30 | (m) | (m) | $1.27M | $216.58M | (m) | (m) | $569.70M | (m) |
| 2018-06-30 | (m) | (m) | $1.27M | $216.93M | (m) | (m) | $570.45M | (m) |
| 2018-03-31 | (m) | (m) | $1.29M | $217.44M | (m) | (m) | $583.17M | (m) |
| 2017-12-31 | (m) | (m) | $718.00K | $218.24M | (m) | (m) | $589.69M | (m) |
| 2017-09-30 | (m) | (m) | $3.23M | $64.83M | (m) | (m) | $326.14M | (m) |
| 2017-06-30 | (m) | (m) | $3.23M | $65.64M | (m) | (m) | $322.22M | (m) |
| 2017-03-31 | (m) | (m) | $4.79M | $66.45M | (m) | (m) | $319.37M | (m) |
| 2016-12-31 | (m) | (m) | $4.56M | $67.01M | (m) | (m) | $316.14M | (m) |
| 2016-09-30 | (m) | (m) | $1.80M | $69.63M | (m) | (m) | $308.86M | (m) |
| 2016-06-30 | (m) | (m) | $1.80M | $70.44M | (m) | (m) | $303.04M | (m) |
| 2016-03-31 | (m) | (m) | $1.33M | $71.24M | (m) | (m) | $297.16M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |